InvestorsHub Logo
Followers 0
Posts 25
Boards Moderated 0
Alias Born 08/25/2017

Re: anders2211 post# 117740

Tuesday, 08/29/2017 7:10:20 PM

Tuesday, August 29, 2017 7:10:20 PM

Post# of 458336

Gilead bought for $ 9bn an in my few lousy pipeline with 1 very iffy working phase 2 perhaps and maybe med with very bad safety. Completely pumped by hedge funds. Based on this valuation Anavex is worth 2x or 3x that... IMO



I don't think you know KITE. Gilead isn't that stupid. KITE's axi-cel treatment for non Hodgkins Lymphoma is on track for approval in November. It's expected to be approved, after the ADCOMM meeting was completely waived, and the ADCOMM for Novartis's similar CAR-T was unanimously recommended.

And it doesn't have very bad safety. You're talking about people with severe cancer, with terrible outlooks. One person dying compared to extremely good results for many others was, is a game changer. That's why KITE soared over the last year and Gilead bought it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News